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aribbean. Most trips (71.6%, 53.8%, and 72.8% for CAm,
Am and the Caribbean respectively) were <2 weeks dura-
ion. Most traveled for tourism (53.7%, 56.6% and 30.3%
f visitors to CAm, SAm and the Caribbean) while visiting
riends/relatives (VFR) accounted for 7.3%, 13.5% and 23.7%
f visits to these regions, respectively. Caribbean and CAm
ravelers also went for missionary/volunteer work (21.9%
nd 13.3%). Travelers to the Caribbean were more likely
o stay at a local residence (49.8%) than those traveling to
Am or SAm (27.9%/31.9%); however, CAm and SAm travel-
rs were more likely to stay at a hotel/hostel (70%) than
aribbean travelers (40%). More travelers to CAm (65.6%)
nd the Caribbean (68.8%) visited a malaria risk country than
hose traveling to SAm (43.6%). Of the Caribbean travelers
ho were prescribed antimalarials, the vast majority (96%)
ere visiting Haiti and the Dominican Republic. Caribbean
nd CAm travelers were predominantly prescribed chloro-
uine (82.3% and 74.5%) or Malarone (18.6% and 23.7%);
Am travelers appropriately received Malarone (85.4%) or
oxycycline (8.2%).
Conclusion: Caribbean travelers were more likely to
ravel as VFRs or volunteers and stay in local residences than
hose traveling to CAm or SAm. South American travelers vis-
ted for longer periods of time and often to non-malarious
reas. All travelers received antimalarials appropriate for
heir destinations.
oi:10.1016/j.ijid.2010.02.1801
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Background: Hookworm-related Cutaneous Larva Migrans
HrCLM) in travellers is a common but neglected parasitic
kin disease that results from a zoonotic nematode infec-
ion and shows a characteristic creeping eruption due to
enetration and migration of the larva within the epidermis.
Methods: We performed a retrospective survey of
atients with this illness assisted at our Unit from 1999
rough 2008.
Results: A total of 64 individuals received a diagnosis of
rCLM, and among them there were 55 (85.93%) who had
cquired it in the Brazilian beaches, but also in Costa Rica,
araguay, Peru, Senegal, Thailand and Venezuela.
Three patients were domestic travelers and they had
cquired the creeping eruption in Argentina. Fifty percent of
he 64 affected patients were young adults between 20—39
ears. Lesions were mainly unique (90.6%) and affected feet
82.75%).
The symptoms appeared to 70.35% (n = 45) of patients,
etween 3 and 7 days after returning from the trip. Eleven
17.18%) patients had secondary bacterial infection. Out
f 64 patients assisted, 62 (96.87%) were cured by a
ingle course of treatment: 48 patients with ivermectin,
1 with oral thiabendazole plus topics of 10% thiaben-
azole cream; one received oral albendazole, 400mg a
ay for 3 days and one patient’s treatment was not
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ecorded. Two patients (3.12%) required a second course of
herapy.
Conclusion: As travel to the tropics increases, many trav-
lers may be returning to their countries with this infection,
hich is often misdiagnosed or incorrectly treated.
Although there are various treatments available, it is nec-
ssary to have prospective and randomized controlled trial
o compare their efﬁcacy.
Among the preventive measures, that can be suggested
o travelers, are to avoid walking barefoot has proved to
ecrease the disease impact and also reduce the contact of
kin areas with contaminated soil or beaches, by lying on a
anvas for sunbathing or to rest. Furthermore, Public Health
easures must be put into practice to avoid the presence of
oose animals and to promote deworming of the same.
oi:10.1016/j.ijid.2010.02.1802
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Background: As both international travel and the num-
er of immunocompromised travellers increase, concerns
elated to the efﬁcacy of immunizations and malaria pro-
hylaxis, drug interactions and worse of the basal medical
ondition in this population are a challenge for practitioners.
Methods: The charts from pre-traveller appointments
f consecutive travellers were reviewed selecting our
arget population: those with HIV infection, malignant
iseases in treatment, solid organ or stem cell recep-
ors, under immunossupressive therapy and splenectomized.
emograﬁc data, destination, duration and reasons of
ravel, malaria quimioprophylaxis and immunizations were
onsidered.
Results: From the 2101 travelers 23 (1,1%) meet crite-
ia for immunosuppression. Eleven (48%) had HIV infection
all with CD4+ counts between 200-500/ul, 5 AIDS, 8 under
AART, 3 HCV co-infected), 10 (43%) were under immunosup-
ressive drugs (7 had autoimmune diseases, 2 solid organ
ransplant receptors, 1 under systemic corticotherapy for
evere asthma), 2 (9%) were splenectomized. Their ages
anged from 21-56 years, mean 41; 17 (74%) were man. Mean
ime between the consultation and the date of travel was
3 days. Africa was the destination of 16 (70%) travelers
13 for Angola), tropical South America in 5 (22%), Indian
ubcontinent and Central America in 1 each. Excluding 2
ravelers (one emigrant and one who lived in the country
f destination) the duration of travel ranged from 3-180
ays, mean 29days. The reason for travelling was work in
2 (52%), tourism in 9 (39%), humanitarian mission in 1 and
was resident. Malaria quimioprophylaxis was indicated in
2 (52%) and in 3 drug interactions changed the the ﬁrst
hoice. Yellow fever vacination was required for 12 travel-
rs, in 6 a medical excuse was done, 4 were vaccinated (2
IV not severe immunosuppressed, 1 was splenectomized,
